Bull case
LRCX would need investors to value it at roughly 75x earnings — about 6x more generous than today's 68x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where LRCX stock could go
LRCX would need investors to value it at roughly 75x earnings — about 6x more generous than today's 68x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 57x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 33x multiple contraction could push LRCX down roughly 48% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Lam Research is a leading manufacturer of semiconductor fabrication equipment used to produce integrated circuits. The company generates revenue primarily from selling wafer fabrication equipment — including etch, deposition, and cleaning systems — and related services, with equipment sales typically representing around 80% of total revenue. Its competitive advantage stems from deep process expertise in critical semiconductor manufacturing steps, particularly in etch and deposition technologies where it holds strong market positions.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.33/$1.21 | +9.9% | $5.2B/$5.0B | +3.3% |
| Q4 2025 | $1.26/$1.22 | +3.3% | $5.3B/$5.2B | +1.9% |
| Q1 2026 | $1.27/$1.17 | +8.5% | $5.3B/$5.2B | +2.1% |
| Q2 2026 | $1.47/$1.36 | +8.1% | $5.8B/$5.8B | +1.6% |
LRCX beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $364 — implies -6.4% from today's price.
| Metric | LRCX | S&P 500 | Technology | 5Y Avg LRCX |
|---|---|---|---|---|
| Forward PE | 68.5x | 18.8x+264% | 22.3x+208% | — |
| Trailing PE | 93.7x | 24.4x+283% | 29.0x+223% | 23.1x+305% |
| PEG Ratio | 4.18x | 1.66x+152% | 1.51x+178% | — |
| EV/EBITDA | 77.0x | 15.2x+406% | 16.6x+363% | 19.1x+304% |
| Price/FCF | 89.7x | 20.7x+334% | 19.2x+367% | 25.4x+253% |
| Price/Sales | 26.4x | 3.1x+752% | 2.4x+981% | 6.2x+326% |
| Dividend Yield | 0.23% | 1.91% | 1.11% | 0.96% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolLRCX generates $6.5B in free cash flow at a 29.8% margin — 55.7% ROIC signals a durable competitive advantage.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
The shortage of cleanroom space presents a tangible risk that could significantly delay Lam Research's revenue growth.
Lam Research faces revenue risks due to high customer concentration, particularly its connection with SK Hynix.
U.S. export controls on semiconductor equipment to China pose a risk to Lam Research's revenue, given its exposure to the Chinese market.
Lam Research's revenue is tied to memory capital expenditure cycles, which can be volatile and impact financial performance.
The company's dilution risk is assessed as low, with a recent stock split completed in October.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
Lam Research Corporation holds a leading position in semiconductor etching and deposition technologies, which are critical for advanced chip manufacturing.
The company benefits from a growing stream of high-margin service revenue, bolstering its financial performance.
Strong demand for AI infrastructure is driving growth, with Lam Research well-positioned to capitalize on this trend.
The company is seeing increased demand for its solutions in advanced packaging applications, a key growth area in semiconductor manufacturing.
Lam Research has reported ten consecutive quarters of revenue growth, including a 22% year-over-year increase in Q2 fiscal 2026.
The company is known for its relentless pursuit of innovation, pushing technical boundaries to create cutting-edge semiconductor solutions.
Recent stronger-than-expected results and an upgraded wafer fab equipment market outlook reflect surging demand tied to AI and advanced packaging.
Lam Research's products are essential in front-end wafer processing, a critical step in creating active semiconductor components.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
LRC LRCX Lam Research Corporation | $485.8B | 68.5x | +10.2% | 30.9% | Buy | -10.2% |
AMA AMAT Applied Materials, Inc. | $490.0B | 50.5x | +11.5% | 29.3% | Buy | -13.5% |
KLA KLAC KLA Corporation | $34.2B | 70.0x | +8.9% | 35.7% | Buy | +640.1% |
ASM ASML ASML Holding N.V. | $749.0B | 59.6x | +16.2% | 29.4% | Buy | -12.2% |
TER TER Teradyne, Inc. | $68.6B | 59.4x | +10.5% | 22.6% | Buy | -19.8% |
ONT ONTO Onto Innovation Inc. | $16.6B | 46.5x | +11.5% | 10.3% | Buy | +1.5% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
LRCX returns capital mainly through $3.4B/year in buybacks (0.7% buyback yield), with a modest 0.23% dividend — combining for 0.9% total shareholder yield. The dividend has grown for 12 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.52 | — | — | — |
| 2025 | $0.98 | +14.0% | 2.7% | 3.6% |
| 2024 | $0.86 | +15.4% | 2.0% | 2.7% |
| 2023 | $0.74 | +15.5% | 2.4% | 3.5% |
| 2022 | $0.65 | +15.2% | 6.1% | 7.4% |
Common questions answered from live analyst data and company financials.
Lam Research Corporation (LRCX) is rated Buy by Wall Street analysts as of 2026. Of 50 analysts covering the stock, 39 rate it Buy or Strong Buy, 10 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $349, implying -10.2% from the current price of $389. The bear case scenario is $203 and the bull case is $424.
The Wall Street consensus price target for LRCX is $349 based on 50 analyst estimates. The high-end target is $575 (+47.8% from today), and the low-end target is $275 (-29.3%). The base case model target is $322.
LRCX trades at 68.5x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals fair versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for LRCX in 2026 are: (1) Cleanroom space shortages — The shortage of cleanroom space presents a tangible risk that could significantly delay Lam Research's revenue growth. (2) Customer concentration risk — Lam Research faces revenue risks due to high customer concentration, particularly its connection with SK Hynix. (3) U.S. export controls — U. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates LRCX will report consensus revenue of $23.9B (+10.2% year-over-year) and EPS of $5.69 (+6.6% year-over-year) for the upcoming fiscal year. The following year, analysts project $27.4B in revenue.
Lam Research Corporation is expected to report its next earnings on approximately 2026-07-29. Consensus expects EPS of $1.65 and revenue of $6.6B. Over recent quarters, LRCX has beaten EPS estimates 92% of the time.
Lam Research Corporation (LRCX) generated $6.5B in free cash flow over the trailing twelve months — a free cash flow margin of 29.8%. LRCX returns capital to shareholders through dividends (0.2% yield) and share repurchases ($3.4B TTM).